Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
28/10/2025 06:26
Oct 28 (Reuters) - NOVARTIS AG NOVN.S: ANNOUNCES EXPIRATION OF TOURMALINE BIO TENDER OFFER OFFER PRICE SET AT $48.00 PER SHARE EXPECT TRANSACTION TO CLOSE ON OCTOBER 28, 2025 24,030,382 SHARES TENDERED, REPRESENTING 92.94% OF OUTSTANDING SHARES Further company coverage: NOVN.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy